Investing.com -- Dyne Therapeutics, Inc. (Nasdaq:DYN) stock fell 23% after the company announced an updated plan for obtaining U.S. Accelerated Approval for DYNE-101 in myotonic dystrophy type 1 (DM1) ...

Rosenthal said the Giants’ history of swinging and missing on high-profile sluggers — specifically naming the missed trade ...

A Spanish court has convicted four people who hung an effigy of Real Madrid star Vinícius Júnior off a highway bridge two years ago, the league said on Monday. The defendants were ...

Understanding the distinction between standalone and consolidated financial results is vital for investors. Standalone ...

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.

In the current Australian market, energy stocks have been in focus due to geopolitical tensions affecting Brent Crude prices, while other sectors like metals and mining have experienced volatility.

Currently, Collegium Pharmaceutical shares are trading down 0.0%, priced at $29.69 during Thursday's morning. This values MD's 15,000 shares at $243,600.

Agentic AI refers to a type of artificial intelligence that focuses on creating autonomous systems capable of making ...

Mineralys Therapeutics, Inc.'s lorundrostat shows promise for treating aldosterone-driven hypertension with FDA approval by ...

The Code of Conduct for Prevention of Insider Trading must be immediately updated to reflect the expanded definitions of UPSI, “connected persons,” and “relatives.” Clearly articulate the implications ...

However, on the same day, she also purchased 25 shares without seeking approval from the compliance officer, breaching the company’s Code of Conduct for the Prevention of Insider Trading.

Biotech mogul Sam Waksal – who landed in prison two decades ago over the ImClone insider trading scandal that ... tested an illegal “swine drug” treatment on a child with epilepsy, according ...